Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03068897 · ClinicalTrials.gov registry record · Phase 4
Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain
A Phase 4 study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 320
- Enrollment target
NCT03068897 is a Phase 4 study that has completed, run by Montefiore Medical Center. The registered enrollment target is 320 participants.
The verdict
NCT03068897, a Phase 4 study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 320 participants
- Enrollment target
Study Summary
This is a randomized study, based in emergency departments, in which the investigators determine the utility of adding various skeletal muscle relaxants to standard therapy, which consists of ibuprofen and an educational session. Patients will be enrolled at the time of an emergency visit and followed for three months to determine outcomes.
Interventions
- DRUG Ibuprofen 600 mg
- BEHAVIORAL Educational intervention
- DRUG Tizanidine
- DRUG Baclofen
- DRUG Metaxalone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2017-05-03 |
| Est. Completion | 2018-10-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03068897
The ClinicalTrials.gov registry entry for NCT03068897 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Ibuprofen 600 mg is the first listed.
NCT03068897 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03068897 about?
NCT03068897 is a clinical study titled "Ibuprofen Plus Metaxolone, Tizanidine, or Baclofen for Low Back Pain". This is a randomized study, based in emergency departments, in which the investigators determine the utility of adding various skeletal muscle relaxants to standard therapy, which consists of ibuprofen and an educational session. Patients will be enrolled at the time of an emergency visit and follow...
What is the current status of trial NCT03068897?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 320 participants. The study started on 2017-05-03. Estimated completion is 2018-10-11.
What interventions are being tested in trial NCT03068897?
The interventions under investigation include: Ibuprofen 600 mg (DRUG), Educational intervention (BEHAVIORAL), Tizanidine (DRUG), Baclofen (DRUG), Metaxalone (DRUG).
Who is sponsoring clinical trial NCT03068897?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.